Skip to content

Clinical trials

Phase 3 trials in Uzbekistan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Country / region: Uzbekistan Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20192
20202
20222
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting2
Unknown status2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.2
Mirum Pharmaceuticals, Inc.2
Pharmasoft2
R-Pharm1
Shanghai Vinnerna Biosciences Co., Ltd.1
Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis D2
Stroke2
Brain Ischemia1
COVID-191
Central Nervous System Diseases1
Cerebrovascular Disorders1
Cognitive Dysfunction1
Hypoxia, Brain1
Ischemia1
Ischemic Stroke1

Trials

Showing 76 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.